These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29376863)

  • 1. Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration.
    Saraceno C; Catania M; Paterlini A; Fostinelli S; Ciani M; Zanardini R; Binetti G; Di Fede G; Caroppo P; Benussi L; Ghidoni R; Bolognin S
    J Alzheimers Dis; 2018; 61(4):1477-1483. PubMed ID: 29376863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study.
    Vignini A; Morganti S; Salvolini E; Sartini D; Luzzi S; Fiorini R; Provinciali L; Di Primio R; Mazzanti L; Emanuelli M
    Exp Gerontol; 2013 Dec; 48(12):1505-8. PubMed ID: 24400342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype.
    Connelly SJ; Mukaetova-Ladinska EB; Abdul-All Z; Alves da Silva J; Brayne C; Honer WG; Mann DM
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):366-80. PubMed ID: 21073671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does executive impairment define a frontal variant of Alzheimer's disease?
    Woodward M; Brodaty H; Boundy K; Ames D; Blanch G; Balshaw R;
    Int Psychogeriatr; 2010 Dec; 22(8):1280-90. PubMed ID: 20719041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer's disease: evidence from the Frontal Behavioral Inventory.
    Konstantinopoulou E; Aretouli E; Ioannidis P; Karacostas D; Kosmidis MH
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):939-46. PubMed ID: 23135894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.
    Baldeiras I; Santana I; Leitão MJ; Ribeiro MH; Pascoal R; Duro D; Lemos R; Santiago B; Almeida MR; Oliveira CR
    J Neurol Sci; 2015 Nov; 358(1-2):308-16. PubMed ID: 26388316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
    J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of microglial cell activation in frontotemporal lobar degeneration.
    Lant SB; Robinson AC; Thompson JC; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Gerhard A; Mann DM
    Neuropathol Appl Neurobiol; 2014 Oct; 40(6):686-96. PubMed ID: 24117616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
    Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
    Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
    Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
    Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.
    van Eersel J; Stevens CH; Przybyla M; Gladbach A; Stefanoska K; Chan CK; Ong WY; Hodges JR; Sutherland GT; Kril JJ; Abramowski D; Staufenbiel M; Halliday GM; Ittner LM
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):906-25. PubMed ID: 25763777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
    Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
    Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration.
    Zanardini R; Benussi L; Fostinelli S; Saraceno C; Ciani M; Borroni B; Padovani A; Binetti G; Ghidoni R
    J Alzheimers Dis; 2018; 61(3):1053-1060. PubMed ID: 29226876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration.
    Gibbons L; Rollinson S; Thompson JC; Robinson A; Davidson YS; Richardson A; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Neurobiol Aging; 2015 Mar; 36(3):1603.e1-4. PubMed ID: 25435337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Copper is not Altered in Frontotemporal Lobar Degeneration.
    Squitti R; Fostinelli S; Siotto M; Ferrari C; Binetti G; Benussi L; Rongioletti M; Ghidoni R
    J Alzheimers Dis; 2018; 63(4):1427-1432. PubMed ID: 29843237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical event-related potentials in Alzheimer's disease and frontotemporal lobar degeneration.
    Chen L; Zhou Y; Liu L; Zhang X; Zhang H; Liu S
    J Neurol Sci; 2015 Dec; 359(1-2):88-93. PubMed ID: 26671093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the driving behaviours of individuals with frontotemporal lobar degeneration and those with Alzheimer's disease.
    Fujito R; Kamimura N; Ikeda M; Koyama A; Shimodera S; Morinobu S; Inoue S
    Psychogeriatrics; 2016 Jan; 16(1):27-33. PubMed ID: 25735319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.